Want to see KR:004080 full AI Analyst Report?
Top Page
Shinhung Co., Ltd
(004080)
Select Model
Select Model
Rating:58Neutral
Price Target:
₩14,934.00
Action:N/A
Date:10/28/26
The score is primarily constrained by negative TTM operating and free cash flow despite improved revenue and margins, which reduces earnings quality and visibility. A conservatively levered balance sheet provides stability, while technicals are neutral-to-slightly constructive. Valuation is moderate-to-premium (P/E ~24) with a modest dividend yield, limiting upside if cash generation does not normalize.
Positive Factors
Revenue and Margin Recovery
The sharp TTM revenue rebound and improved margins indicate recovering operating performance and stronger earnings capacity. If maintained, this improvement can support reinvestment, strengthen the company’s competitive position, and rebuild profitability toward earlier levels over the coming quarters.
Negative Factors
Negative Cash Conversion
Negative operating and free cash flow weakens earnings quality because reported profits are not currently translating into cash. The deterioration can increase reliance on balance-sheet resources, constrain reinvestment, and raise funding risk until working-capital or investment pressures normalize.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and Margin Recovery
The sharp TTM revenue rebound and improved margins indicate recovering operating performance and stronger earnings capacity. If maintained, this improvement can support reinvestment, strengthen the company’s competitive position, and rebuild profitability toward earlier levels over the coming quarters.
Read all positive factors
Shinhung Co., Ltd (004080) vs. SPDR S&P 500 ETF (SPY)
Market Cap
₩131.32B
Dividend Yield2.44%
Average Volume (3M)4.72K
Price to Earnings (P/E)24.1
Beta (1Y)<0.01
Revenue Growth7.30%
EPS Growth17.00%
CountryKR
Employees208
SectorGeneral
Sector StrengthN/A
IndustryMedical - Devices
Share Statistics
EPS (TTM)592.51
Shares Outstanding9,200,000
10 Day Avg. Volume5,361
30 Day Avg. Volume4,717
Financial Highlights & Ratios
PEG Ratio-1.03
Price to Book (P/B)1.10
Price to Sales (P/S)1.24
P/FCF Ratio-80.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Shinhung Co., Ltd Business Overview & Revenue Model
Company Description
Operating primarily in South Korea, Shinhung Co., Ltd. specializes in the production and distribution of a comprehensive array of dental goods and supplies. Their extensive product line features sophisticated implant systems and related components...
Shinhung Co., Ltd Financial Statement Overview
Summary
Income Statement
63
Positive
Balance Sheet
78
Positive
Cash Flow
34
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 105.89B | 102.61B | 101.76B | 112.44B | 118.18B | 126.85B |
| Gross Profit | 33.03B | 31.95B | 30.93B | 36.04B | 34.76B | 37.03B |
| EBITDA | 11.36B | 9.27B | 10.09B | 15.29B | 13.65B | 23.61B |
| Net Income | 5.36B | 2.82B | 5.23B | 9.23B | 8.46B | 13.45B |
Balance Sheet | ||||||
| Total Assets | 157.24B | 149.63B | 141.43B | 140.33B | 140.62B | 138.61B |
| Cash, Cash Equivalents and Short-Term Investments | 1.61B | 1.83B | 6.10B | 9.17B | 8.46B | 6.91B |
| Total Debt | 17.33B | 11.27B | 3.99B | 8.90B | 7.48B | 6.80B |
| Total Liabilities | 39.86B | 33.63B | 25.27B | 26.44B | 33.76B | 37.20B |
| Stockholders Equity | 116.71B | 115.40B | 115.67B | 113.89B | 106.86B | 101.42B |
Cash Flow | ||||||
| Free Cash Flow | -5.59B | -1.59B | 5.65B | 1.66B | 960.02M | 974.29M |
| Operating Cash Flow | -2.17B | 1.93B | 9.58B | 7.64B | 4.42B | 3.34B |
| Investing Cash Flow | 324.84M | -5.13B | -3.63B | -7.39B | -4.87B | 14.90B |
| Financing Cash Flow | 2.28B | 3.51B | -7.20B | -449.50M | -2.60B | -12.58B |
Shinhung Co., Ltd Technical Analysis
Neutral
―
Price Trends
14242.20
Positive
14050.12
Positive
13853.23
Positive
Market Momentum
25.72
Positive
51.02
Neutral
55.28
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:004080, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 14385.00, equal to the 50-day MA of 14242.20, and equal to the 200-day MA of 13853.23, indicating a neutral trend. The MACD of 25.72 indicates Positive momentum. The RSI at 51.02 is Neutral, neither overbought nor oversold. The STOCH value of 55.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for KR:004080.
Shinhung Co., Ltd Peers Comparison
UnderperformOutperform
Sector (55)
KR:004080
Shinhung Co., Ltd
14,350.00
894.24
6.65%
KR:032620
GC MediAI Corporation
2,900.00
-596.35
-17.06%
KR:226590
MDEVICE Co., Ltd
10,190.00
-8,610.00
-45.80%
KR:240550
Dongbang Medical Co., Ltd.
5,300.00
-3,920.00
-42.52%
KR:394420
RecensMedical, Inc.
5,600.00
-12,850.00
-69.65%
KR:418550
JEIO Co., Ltd.
4,390.00
-4,530.00
-50.78%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.